Novel approach identifies highly specific anti-cancer compounds
2 monkeypox strains in US suggest possible undetected spread
3 June 2022Researchers develop newly redefined breast cancer response subtypes
4 June 2022Novel approach identifies highly specific anti-cancer compounds
Researchers at Baylor College of Medicine and Texas Children’s Hospital have identified potent, highly specific compounds that interfere with bromodomain (BD)-containing proteins involved in cancer. The compounds, called BET BD1-inhibitors, are a starting point in the development of potentially more effective anti-cancer drugs with less side effects.
